Related Experiment Video
Updated: Aug 11, 2026

22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
Published on: February 25, 2007
Radiation sensitivity of the hemopoietic stem cell
1Institute of Applied Radiobiology and Immunology, Rijswijk, The Netherlands.
Radiation Research
|October 1, 1991
Summary
The study investigated hemopoietic stem cell radioresistance after total-body irradiation (TBI). Findings suggest a radioresistant subpopulation exists, but it is not due to hypoxic conditions.
Area of Science:
- Radiobiology
- Hematology
- Stem Cell Biology
Background:
- The LD50/30 after total-body irradiation (TBI) reflects animal radiosensitivity, determined by hemopoietic stem cells.
- Pluripotential stem cells are crucial, with mouse models extensively studied using spleen colony assays.
- In vitro assays like CFU-S and CFU-C quantify stem cells, but show variability in radiosensitivity parameters (D0 and N).
Purpose of the Study:
- To estimate hemopoietic stem cell surviving fractions at higher radiation doses (5-10 Gy) than typically studied.
- To investigate the hypothesis that a radioresistant stem cell subpopulation exists, potentially due to hypoxia.
- To determine the relative biological effectiveness (RBE) of fission neutrons for stem cell survival and lethality.
Main Methods:
- Derived stem cell surviving fractions using peripheral blood cell repopulation data in monkeys and spleen/bone marrow repopulation in mice after high-dose TBI.
- Calculated theoretical D0 values for hemopoietic stem cells.
- Determined RBEs for CFU-S survival and LD50/30 in BCBA mice using fission neutrons.
Main Results:
- Estimates of hemopoietic stem cell surviving fractions were derived for radiation doses between 5 and 10 Gy.
- Data suggest a small subpopulation of hemopoietic stem cells exhibits higher radioresistance than the majority.
- The RBEs for CFU-S survival and LD50/30 were similar, indicating the radioresistance is not due to hypoxia.
Conclusions:
- The radioresistance of the stem cell subpopulation responsible for survival at high doses is not attributable to hypoxic conditions.
- This finding has implications for understanding radiation effects on the hematopoietic system and developing radioprotective strategies.
Related Concept Videos
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment
Commitment is the process whereby stem cells:
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

